These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 12396452)

  • 1. Correlates of antiviral immune restoration in acute and chronic HIV type 1 infection: sustained viral suppression and normalization of T cell subsets.
    Dyer WB; Kuipers H; Coolen MW; Geczy AF; Forrester J; Workman C; Sullivan JS
    AIDS Res Hum Retroviruses; 2002 Sep; 18(14):999-1010. PubMed ID: 12396452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poor lymphoproliferative responses with low proportion of Gag-specific CD8 TEMRA cells in HIV-1-infected patients showing immunological and virological discordance despite prolonged suppression of plasma viremia.
    Sachdeva N; Weinstein JE; Ashman M; Sachdeva M; Brewer TH; Gracia D; Asthana D
    Viral Immunol; 2010 Feb; 23(1):49-61. PubMed ID: 20121402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in cellular activation and apoptosis in HIV-infected patients receiving protease inhibitors or nonnucleoside reverse transcriptase inhibitors.
    Benito JM; López M; Martín JC; Lozano S; Martínez P; González-Lahoz J; Soriano V
    AIDS Res Hum Retroviruses; 2002 Dec; 18(18):1379-88. PubMed ID: 12487809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.
    López M; Soriano V; Rallón N; Cascajero A; González-Lahoz J; Benito JM
    Eur J Immunol; 2008 Jun; 38(6):1548-58. PubMed ID: 18421792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy.
    Benito JM; López M; Lozano S; González-Lahoz J; Soriano V
    J Infect Dis; 2008 Nov; 198(10):1466-73. PubMed ID: 18847371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell responses to highly active antiretroviral therapy defined by chemokine receptors expression, cytokine production, T cell receptor repertoire and anti-HIV T-lymphocyte activity.
    Giovannetti A; Pierdominici M; Mazzetta F; Salemi S; Marziali M; Kuonen D; Iebba F; Lusi EA; Cossarizza A; Aiuti F
    Clin Exp Immunol; 2001 Apr; 124(1):21-31. PubMed ID: 11359439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-year immune reconstitution in PI-sparing and PI-containing antiretroviral regimens in advanced HIV-1 disease.
    Samri A; Goodall R; Burton C; Imami N; Pantaleo G; Kelleher A; Poli G; Gotch F; Autran B
    Antivir Ther; 2007; 12(4):553-8. PubMed ID: 17668564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic effects of combined protease inhibitor and reverse transcriptase inhibitor therapy in previously treated chronic HIV-1 infection.
    Giorgi JV; Majchrowicz MA; Johnson TD; Hultin P; Matud J; Detels R
    AIDS; 1998 Oct; 12(14):1833-44. PubMed ID: 9792384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconstitution of virus-specific CD4 proliferative responses in pediatric HIV-1 infection.
    Feeney ME; Draenert R; Roosevelt KA; Pelton SI; McIntosh K; Burchett SK; Mao C; Walker BD; Goulder PJ
    J Immunol; 2003 Dec; 171(12):6968-75. PubMed ID: 14662905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central memory CD4 T cells are associated with incomplete restoration of the CD4 T cell pool after treatment-induced long-term undetectable HIV viraemia.
    Rallón N; Sempere-Ortells JM; Soriano V; Benito JM
    J Antimicrob Chemother; 2013 Nov; 68(11):2616-25. PubMed ID: 23833186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.
    Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T
    J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART).
    Gray CM; Lawrence J; Schapiro JM; Altman JD; Winters MA; Crompton M; Loi M; Kundu SK; Davis MM; Merigan TC
    J Immunol; 1999 Feb; 162(3):1780-8. PubMed ID: 9973442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia.
    Zaunders JJ; Cunningham PH; Kelleher AD; Kaufmann GR; Jaramillo AB; Wright R; Smith D; Grey P; Vizzard J; Carr A; Cooper DA
    J Infect Dis; 1999 Aug; 180(2):320-9. PubMed ID: 10395845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
    Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
    Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection.
    Dyer WB; Zaunders JJ; Yuan FF; Wang B; Learmont JC; Geczy AF; Saksena NK; McPhee DA; Gorry PR; Sullivan JS
    Retrovirology; 2008 Dec; 5():112. PubMed ID: 19077215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional patterns of HIV-1-specific CD4 T-cell responses in children are influenced by the extent of virus suppression and exposure.
    Correa R; Harari A; Vallelian F; Resino S; Munoz-Fernandez MA; Pantaleo G
    AIDS; 2007 Jan; 21(1):23-30. PubMed ID: 17148964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal assessment of immune response and viral characteristics in HIV-infected patients with prolonged CD4(+)/viral load discordance.
    Kaplan SS; Ferrari G; Wrin T; Hellmann NS; Tomaras GD; Gryszowka VE; Fiscus SA; Weinhold KJ; Hicks CB
    AIDS Res Hum Retroviruses; 2005 Jan; 21(1):13-6. PubMed ID: 15665640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 viral replication below 50 copies/ml in patients on antiretroviral therapy is not associated with CD8+ T-cell activation.
    Steel A; Cox AE; Shamji MH; John L; Nelson M; Henderson DC; Gotch FM; Gazzard BG; Kelleher P
    Antivir Ther; 2007; 12(6):971-5. PubMed ID: 17926652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited immune restoration after 3 years' suppression of HIV-1 replication in patients with moderately advanced disease.
    Valdez H; Connick E; Smith KY; Lederman MM; Bosch RJ; Kim RS; St Clair M; Kuritzkes DR; Kessler H; Fox L; Blanchard-Vargas M; Landay A;
    AIDS; 2002 Sep; 16(14):1859-66. PubMed ID: 12351945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CD160+ CD8high cytotoxic T cell subset correlates with response to HAART in HIV-1+ patients.
    Nikolova MH; Muhtarova MN; Taskov HB; Kostov K; Vezenkov L; Mihova A; Boumsell L; Bensussan A
    Cell Immunol; 2005 Oct; 237(2):96-105. PubMed ID: 16337931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.